The TNFRSF11A gene gives your body instructions for RANK, a signaling protein that helps control how bone is broken down and rebuilt, and it also supports parts of the immune system. This gene plays an important role in keeping bones strong but balanced. If it does not work properly, bone turnover can become too low or too high, which may lead to unusually dense bones, bone pain, fractures, or delayed tooth eruption. Certain pathogenic variants in the TNFRSF11A gene are linked to rare inherited bone conditions.
What is a gene?
Genes are sections of DNA that hold instructions your cells use to make molecules or direct processes in the body. Some genes carry the information needed to produce proteins, which do much of the cell’s work. Other genes mainly control when certain processes happen, where they happen, and how strongly they run. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. To go into this topic in more detail, you can learn more in LearnHub.
Overview
TNFRSF11AGene function
What if the gene works
The TNFRSF11A gene helps control how bone is broken down and rebuilt, which supports normal bone growth and strength. It also helps certain immune cells communicate and develop.
Risk
What if the gene does not work
Variants in the TNFRSF11A gene mainly affect bone remodeling. Milder to more severe changes can cause overly dense bones with delayed tooth eruption, or increased bone breakdown with pain and deformity; some variants also affect sweating and immune function.
Treatment
What does that mean for your treatment
With loss-of-function variants in the TNFRSF11A gene, a blood stem cell transplant may be used because donor cells can restore the cells that remove old bone. This distinguishes disease linked to the TNFRSF11A gene from some related gene changes where transplant does not correct the underlying cause. No drug treatment is established specifically for the TNFRSF11A gene.
Conditions associated with TNFRSF11A
Gene function
What if the gene works
In daily life, your skeleton stays healthy by replacing small areas of old bone with new bone. The TNFRSF11A gene helps control this cycle by making a receptor that receives the RANKL signal. That message is important for cells that clear away worn bone so fresh bone can be laid down. It also supports some routine immune cell communication.
The TNFRSF11A gene helps form and activate osteoclasts, the cells that remove older bone. This is a normal part of how bones break down and rebuild throughout life.
It makes a receptor on the cell surface that listens for the RANKL signal from nearby cells. After that signal arrives, the cell can turn on programs for activity, survival, and full development.
This gene also helps certain immune cells, including dendritic cells, receive and pass along important messages. During development, it supports the formation of some lymph tissue, including lymph nodes.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change a gene’s function more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the TNFRSF11A gene can change the RANK receptor so it is missing, unstable, kept inside the cell, or switched on for too long. This is how TNFRSF11A gene variants affect bone remodeling: loss-of-function changes reduce signaling needed to form osteoclasts, while activating duplications can make signaling too strong. Milder variants may leave some activity, but more severe variants can lead to earlier or more marked skeletal changes.
How variants are linked to conditions
Pathogenic variants in the TNFRSF11A gene cause several rare inherited bone conditions. The best established variants in the TNFRSF11A gene linked to bone disease include familial expansile osteolysis, expansile skeletal hyperphosphatasia, and some cases of early-onset Paget disease of bone, while other variants can cause a rare form of osteopetrosis. These conditions may affect bone shape, pain, hearing, tooth eruption, and growth.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of being human and are widely found in the general population. Most do not directly affect health and instead reflect normal human variation. For many genes, carrying a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences also play a role. In some situations, though, one well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific lifestyle or environmental factors that clearly increase or reduce health risks related to the TNFRSF11A gene. In families with a disease-causing change in TNFRSF11A, the gene change itself is usually the main driver of risk, while day-to-day factors are less clearly defined.
Inheritance of TNFRSF11A variants
TNFRSF11A-related conditions do not follow just one pattern. The TNFRSF11A inheritance pattern depends on the specific condition and variant type: some bone conditions linked to the TNFRSF11A gene are inherited in an autosomal dominant way, so a parent with the variant can pass it to each child with a 50% chance, while other TNFRSF11A-related conditions are autosomal recessive, which means a child must inherit one altered copy from each parent. In recessive families, parents are often healthy carriers.
What does my TNFRSF11A result mean for my family?
TNFRSF11A results can have different meanings for families because this gene is linked to more than one inherited bone condition. In some families, a changed copy can run from parent to child, so close relatives may also carry the same result. In others, the condition appears only when both copies are changed, which can mean parents are healthy carriers and brothers, sisters, or future children could also be affected or be carriers.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the TNFRSF11A gene, doctors use TNFRSF11A genetic testing for variants, usually on a blood or saliva sample. A lab reads the gene's DNA code to check for a variant that may help explain symptoms or confirm a suspected inherited condition.
When should I consider getting a genetic test?
Consider testing for the TNFRSF11A gene if you or your child has signs of a rare inherited bone condition, such as unusually dense or fragile bones, repeated fractures, bone pain, delayed tooth eruption, or early hearing loss. Testing can also make sense when these problems run in the family or when another relative already has a TNFRSF11A change.
A genetic result is only one part of your health story
Genetic findings can provide useful insight, but how much they reveal varies by the condition and the specific type of variant. Many factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, genetic results can also help place personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, transports, or responds to a drug, so the same treatment may work better for one person than another. This is common and can influence both how well a medicine helps and how likely someone is to notice side effects.
What is Pharmacogenetics?
Pharmacogenetics is the area of study focused on how differences in genes affect the way people respond to medicines. It examines relationships between genes and medications to help explain why the same treatment can work differently from one person to another. For many drugs, genes influence either how strongly a medicine works or how the body handles it. This information can support treatment decisions that are both better informed and more individualized. To explore this subject further, you can learn more in the LearnHub.
Drugs influenced by the TNFRSF11A gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dosing, so questions about medicines, side effects, or bone health are best discussed with your doctor. TNFRSF11A has been studied in research on bone-targeted treatments, but that work is not used on its own to guide routine prescribing.
History
TNFRSF11A entered medical research as scientists worked to understand rare inherited conditions that affect bone strength and shape. In the late 1990s, researchers linked variants in the TNFRSF11A gene to familial expansile osteolysis, a condition that helped reveal an important pathway in bone biology. Building on this early work, scientists connected the same gene to other bone conditions, including some forms of osteopetrosis and early onset Paget disease of bone. These findings helped shift bone genetics from describing visible skeletal changes to identifying the specific genes involved. Over time, descriptions became more precise. Today, TNFRSF11A is recognized as part of the history of major advances in understanding inherited bone conditions.